Chemical structure and sympathomimetic action of amines.
作者信息
Barger G, Dale H H
出版信息
J Physiol. 1910 Oct 11;41(1-2):19-59. doi: 10.1113/jphysiol.1910.sp001392.
Abstract
摘要
相似文献
1
Chemical structure and sympathomimetic action of amines.胺类的化学结构与拟交感神经作用。
J Physiol. 1910 Oct 11;41(1-2):19-59. doi: 10.1113/jphysiol.1910.sp001392.
2
The action of sympathomimetic amines on the central nervous system and the blood sugar; relation of chemical structure to mechanism of action.拟交感胺对中枢神经系统及血糖的作用；化学结构与作用机制的关系。
J Pharmacol Exp Ther. 1950 Jan;98(1):62-71.
3
4
Sympathomimetic amines: the relation of structure to their action and inactivation.拟交感胺类：结构与其作用及失活的关系。
Physiol Rev. 1946 Apr;26:169-97. doi: 10.1152/physrev.1946.26.2.169.
5
Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut.拟交感胺对肠道5-羟色胺受体的兴奋作用。
Br J Pharmacol. 1969 Mar;35(3):383-93. doi: 10.1111/j.1476-5381.1969.tb08280.x.
6
Studies on the mechanism of action of sympathomimetic amines; the effect of various amines on the synthesis of cocarboxylase.拟交感神经胺类药物作用机制的研究；各种胺类对羧化辅酶合成的影响。
J Pharmacol Exp Ther. 1945 Oct;85:140-2.
7
Studies on the mechanism of action of sympathomimetic amines.拟交感神经胺类药物作用机制的研究。
J Pharmacol Exp Ther. 1945 Oct;85:140-9.
8
The sympathomimetic vasodilating action of the aliphatic amines.脂肪族胺类的拟交感神经血管舒张作用。
J Pharmacol Exp Ther. 1945 Nov;85:283-7.
9
The action of sympathomimetic amines on the isolated heart of the frog.拟交感胺对青蛙离体心脏的作用。
J Pharmacol Exp Ther. 1949 Aug;96(4 Pt. 1):365-71.
引用本文的文献
1
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β-Agonists Used for Asthma and COPD.用于哮喘和慢性阻塞性肺疾病的当前短效、长效和超长效β受体激动剂的分子药理学特性比较
Pharmacol Res Perspect. 2025 Oct;13(5):e70154. doi: 10.1002/prp2.70154.
2
Reappraisal of the mechanism of cardiovascular responses to sympathomimetic amines in anaesthetised rats: dual α-adrenoceptor and trace amine receptor mechanisms.麻醉大鼠对拟交感胺心血管反应机制的重新评估：双α-肾上腺素能受体和痕量胺受体机制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2627-2639. doi: 10.1007/s00210-024-03218-0. Epub 2024 Sep 6.
3
The role of the brain renin-angiotensin system in Parkinson´s disease.脑肾素-血管紧张素系统在帕金森病中的作用。
Transl Neurodegener. 2024 Apr 15;13(1):22. doi: 10.1186/s40035-024-00410-3.
4
Evaluation of atherosclerosis as a risk factor in COPD patients by measuring the carotid intima-media thickness.评估颈动脉内膜中层厚度在 COPD 患者中的动脉粥样硬化作为危险因素的价值。
Cardiovasc Ultrasound. 2024 Jan 10;22(1):2. doi: 10.1186/s12947-023-00322-8.
5
The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics.慢性阻塞性肺疾病（COPD）的分子蓝图：诊断和治疗的新模式。
Oxid Med Cell Longev. 2023 Dec 21;2023:2297559. doi: 10.1155/2023/2297559. eCollection 2023.
6
Suggestion of creatine as a new neurotransmitter by approaches ranging from chemical analysis and biochemistry to electrophysiology.从化学分析和生物化学到电生理学等方法提出肌酸作为一种新的神经递质。
Elife. 2023 Dec 21;12:RP89317. doi: 10.7554/eLife.89317.
7
Minding the gap: discovering the phenomenon of chemical transmission in the nervous system.关注差距：发现神经系统中化学传递现象。
Hist Philos Life Sci. 2023 Oct 25;45(4):37. doi: 10.1007/s40656-023-00591-6.
8
L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.左旋多巴治疗帕金森病：来自维也纳和柏林的关于左旋多巴治疗的一些个人思考。
J Neural Transm (Vienna). 2023 Nov;130(11):1323-1335. doi: 10.1007/s00702-023-02692-9. Epub 2023 Oct 5.
9
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD：聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
10
Inflammatory Bowel Disease: Crosstalk between Histamine, Immunity, and Disease.炎症性肠病：组胺、免疫与疾病的串扰。
Int J Mol Sci. 2023 Jun 9;24(12):9937. doi: 10.3390/ijms24129937.
Zotero 插件